Mahipal Suraneni

652 citations
10 papers · 497 indexed · h-index 8
Topics
Cancer Cells and Metastasis (5 papers)Prostate Cancer Treatment and Research (4 papers)Cancer Research and Treatments (2 papers)

In The Last Decade

Mahipal Suraneni

10 papers receiving 495 citations

Peers

Mahipal Suraneni
Comparison fields: 5 of 53
  • Oncology 264
  • Pulmonary and Respiratory Medicine 242
  • Molecular Biology 239
  • Cancer Research 149
  • Immunology 56
Replace Shi-Rong Zhang with:
Shi-Rong Zhang China
Jin-Zhi Xu China
Angela Leo Italy
Marion Richardson France
Funmilayo O. Adeshakin China
Jianshan Mo China
Alicia de las Pozas United States
Kaimi Li China
Kentaro Suina Japan
Tania Valencia United States
Mahipal Suraneni relative to Shi-Rong Zhang China Shi-Rong Zhang's profile →
Citations per field
00.5×6.7×
Shi-Rong Zhang · 1×
Citations per year

Countries citing papers authored by Mahipal Suraneni

Since Specialization
Citations

This map shows the geographic impact of Mahipal Suraneni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahipal Suraneni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahipal Suraneni more than expected).

Fields of papers citing papers by Mahipal Suraneni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahipal Suraneni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahipal Suraneni. The network helps show where Mahipal Suraneni may publish in the future.

Co-authorship network of co-authors of Mahipal Suraneni

This figure shows the co-authorship network connecting the top 25 collaborators of Mahipal Suraneni. A scholar is included among the top collaborators of Mahipal Suraneni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahipal Suraneni. Mahipal Suraneni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 61
2 5
3 1
4 58
5 24
6 27
7
Tumor-Initiating Cells, Cancer Metastasis and Therapeutic Implications
10
8 243
9 37
10 31

About Mahipal Suraneni

Mahipal Suraneni is a scholar working on Biotechnology, Oncology and Cancer Research, having authored 10 papers that have together received 497 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Prostate Cancer Treatment and Research (4 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (149 citations), Oncology (264 citations) and Pulmonary and Respiratory Medicine (242 citations). Mahipal Suraneni has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Dean G. Tang, Collene Jeter, Xin Chen, Xin Liu, Brian Laffin, Jiaoti Huang, Jichao Qin, Hangwen Li, Tammy Calhoun‐Davis and Grace Choy. Their work appears in journals such as Journal of Biological Chemistry, Oncogene and Cell stem cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026